Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 222,011,818 papers from all fields of science
Search
Sign In
Create Free Account
SGB 1534
Known as:
SGB-1534
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
Quinazolines
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
1988
1988
Effect of 3-[2-[4-(o-methoxyphenyl)-1-piperazinyl]ethyl]-2,4(1H,3H)- quinazolinedione monophydrochloride (SGB-1534), an antihypertensive agent, on 3H-prazosin and 3H-p-aminoclonidine binding to alpha…
T. Nagatomo
,
J. Aono
,
A. Tajiri
,
T. Nakamura
,
H. Tsuchihashi
Chemical and pharmaceutical bulletin
1988
Corpus ID: 30678807
In order to assess the antihypertensive activities of SGB-1534, 3-[2-[4-(o-methoxyphenyl)-1-piperazinyl]ethyl]-2, 4-(1H, 3H…
Expand
1988
1988
Effects of ketanserin and 3-[2-[4-(o-methoxyphenyl)-1-piperazinyl]ethyl]-2,4(1H,3H)- quinazolinedione monohydrochloride (SGB-1534), anti-hypertensive agents, on 3H-serotonin and 3H-ketanserin…
T. Nagatomo
,
R. Hokibara
,
Y. Tanaka
,
T. Nakamura
,
J. Aono
,
H. Tsuchihashi
Chemical and pharmaceutical bulletin
1988
Corpus ID: 7096467
Serotonin has an important role in the control of blood pressure, because serotonin2 (5HT2) antagonists ameliorate hypertension…
Expand
1988
1988
[Effects of prazosin, SGB-1534, dobutamine and isoproterenol on congestive heart failure in dogs].
H. Sonoki
,
Y. Uchida
,
T. Tomaru
,
T. Sugimoto
Nihon yakurigaku zasshi. Folia pharmacologica…
1988
Corpus ID: 13194599
Effects of prazosin, dobutamine, isoproterenol and SGB-1534, a new alpha-blockade, on congestive heart failure (CHF) in dogs were…
Expand
1988
1988
Investigations into the mechanism of the antihypertensive effect of SGB-1534, a novel alpha 1-adrenoceptor antagonist, in rats.
J. Aono
,
K. Sakai
Japanese Journal of Pharmacology
1988
Corpus ID: 19470769
Experiments in vitro and in vivo were undertaken to examine possible involvement of a central effect in the hypotensive mechanism…
Expand
1986
1986
Further evaluation of the selectivity of a novel antihypertensive agent, SGB-1534, for peripheral alpha 1-adrenoceptors in the spinally anesthetized dog.
J. Imagawa
,
K. Sakai
European Journal of Pharmacology
1986
Corpus ID: 44663290
1986
1986
Effects of a new antihypertensive agent, SGB-1534, on rat platelet aggregation.
J. Aono
,
K. Sakai
Japanese Journal of Pharmacology
1986
Corpus ID: 40566053
The present study was designed to examine the antiplatelet activity of SGB-1534, 3-[2-[4-(o-methoxyphenyl)-1-piperazinyl]ethyl]-2…
Expand
1986
1986
Potent alpha-adrenoceptor blocking action of SGB-1534, a new quinazoline antihypertensive agent in vitro experiments.
S. Shibata
,
N. Satake
,
+4 authors
F. Flores
General Pharmacology
1986
Corpus ID: 4919707
1985
1985
Antihypertensive effects of a novel phenylpiperazine derivative, SGB-1534, on several hypertensive models of rats.
H. Nabata
,
J. Aono
,
N. Ishizuka
,
K. Sakai
Archives internationales de pharmacodynamie et de…
1985
Corpus ID: 19845895
The antihypertensive activities of SGB-1534, 3-[2-[4-(o-methoxyphenyl)-1-piperazinyl]ethyl]-2,4 (1H,3H)-quinazolinedione…
Expand
1985
1985
Mechanism of the hypotensive effect of a novel phenylpiperazine derivative, SGB-1534: antagonism at alpha 1-adrenergic and 5-HT2 receptors.
J. Aono
,
H. Nabata
,
N. Ishizuka
,
K. Sakai
Archives internationales de pharmacodynamie et de…
1985
Corpus ID: 25235122
The present in vivo and in vitro experiment was designed to examine the hypotensive mechanisms of 3-[2-[4-(o-methoxyphenyl)-1…
Expand
1985
1985
Cardiovascular effects of a novel antihypertensive agent, SGB-1534, in miniature pigs.
K. Sakai
,
O. Kuromaru
,
M. Akima
,
M. Yoshizawa
Archives internationales de pharmacodynamie et de…
1985
Corpus ID: 39935407
The cardiovascular effects of SGB-1534 (3-[2-[4-(o-methoxyphenyl)-1-piperazinyl]-2,4(1H,3H)-quinazolinedione monohydrochloride…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE